Oncologists early ovarian cancer early detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Ovary Epithelial Cells Prostate

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases51

Ovarian Neoplasms Uterine Cervical Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Neoplasms Prostatic Neoplasms Lung Neoplasms Cystadenocarcinoma, Serous Carcinoma Neoplasm Invasiveness Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Genetic Predisposition to Disease Neoplasm Recurrence, Local Disease Progression Colorectal Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Carcinoma, Non-Small-Cell Lung Adenocarcinoma, Mucinous Endometrial Neoplasms Adenocarcinoma Peritoneal Neoplasms Carcinoma, Endometrioid Urinary Bladder Neoplasms Genital Neoplasms, Female Ascites Cell Transformation, Neoplastic Rectal Neoplasms Precancerous Conditions Mouth Neoplasms Head and Neck Neoplasms Liver Neoplasms Esophageal Neoplasms Skin Neoplasms Neovascularization, Pathologic Cystadenocarcinoma Bone Neoplasms Neoplastic Syndromes, Hereditary Gastrointestinal Neoplasms Fallopian Tube Neoplasms Melanoma Neoplasms, Second Primary Disease Models, Animal Neoplasms, Multiple Primary Neoplasms, Radiation-Induced Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Hormone-Dependent Carcinoma, Small Cell

Chemicals and Drugs45

Tumor Markers, Biological CA-125 Antigen Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel Cancer Vaccines RNA, Messenger BRCA2 Protein DNA, Neoplasm BRCA1 Protein Receptors, Estrogen Receptor, erbB-2 Antineoplastic Agents, Phytogenic Antigens, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Epididymal Secretory Proteins Antibodies, Monoclonal Tumor Suppressor Protein p53 Carboplatin Receptors, Progesterone MicroRNAs Fluorouracil DNA Primers Antineoplastic Agents, Hormonal Tumor Suppressor Proteins RNA, Neoplasm Receptor, Epidermal Growth Factor Tamoxifen Antigens, Tumor-Associated, Carbohydrate Deoxycytidine Antibodies, Monoclonal, Humanized DNA-Binding Proteins Taxoids Transcription Factors Biological Markers Proto-Oncogene Proteins Antimetabolites, Antineoplastic Platinum Anticarcinogenic Agents Nuclear Proteins Carcinoembryonic Antigen Radiopharmaceuticals Proto-Oncogene Proteins c-akt

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Early Diagnosis Sensitivity and Specificity Prognosis Neoplasm Staging Survival Analysis Antineoplastic Combined Chemotherapy Protocols Survival Rate Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Reproducibility of Results Prospective Studies Risk Factors Gene Expression Profiling Follow-Up Studies Questionnaires Xenograft Model Antitumor Assays Risk Assessment Risk Disease-Free Survival Chemotherapy, Adjuvant Predictive Value of Tests Combined Modality Therapy Registries Blotting, Western Clinical Trials as Topic Palliative Care Odds Ratio Treatment Outcome Genetic Testing Neoplasm Transplantation SEER Program Oligonucleotide Array Sequence Analysis Immunohistochemistry Multivariate Analysis Incidence Tumor Burden Logistic Models Radiotherapy Transplantation, Heterologous Enzyme-Linked Immunosorbent Assay Limit of Detection Kaplan-Meier Estimate ROC Curve Immunoenzyme Techniques Drug Screening Assays, Antitumor Tissue Array Analysis Molecular Targeted Therapy Neoplasm Grading Biopsy Cohort Studies Tomography, X-Ray Computed Case-Control Studies DNA Mutational Analysis Confidence Intervals Flow Cytometry Transfection Models, Biological Positron-Emission Tomography Breast Self-Examination Pilot Projects Health Care Surveys False Positive Reactions Drug Administration Schedule Diagnostic Imaging Mastectomy Real-Time Polymerase Chain Reaction Gene Knockdown Techniques Disease Models, Animal Radiotherapy, Adjuvant Immunoassay Terminal Care Prevalence Feasibility Studies

Psychiatry and Psychology9

Physician's Role Physician-Patient Relations Attitude of Health Personnel Smoking Communication Decision Making Breast Self-Examination Dissent and Disputes Negativism

Phenomena and Processes42

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Genes, BRCA2 Mutation Risk DNA Methylation Time Factors Odds Ratio Germ-Line Mutation Cell Proliferation Genotype Apoptosis Cell Survival Base Sequence Cell Movement Dose-Response Relationship, Drug Down-Regulation Algorithms Promoter Regions, Genetic Genes, Tumor Suppressor Cell Division Up-Regulation Cell Growth Processes Polymorphism, Genetic Cell Cycle Signal Transduction Transfection Gene Silencing RNA Interference Genes, Neoplasm Gene Expression Phenotype Heterozygote Alleles Genes, p53 Postmenopause Drug Synergism Gene Amplification Epigenesis, Genetic

Disciplines and Occupations7

Medical Oncology Radiation Oncology Immunohistochemistry Hematology Proteomics Genetic Counseling Gynecology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science11

Survival Rate Questionnaires Registries Tape Recording SEER Program Incidence Base Sequence Molecular Sequence Data Algorithms Communication Prevalence

Named Groups3

Medically Uninsured Survivors Physicians

Health Care47

Mass Screening Sensitivity and Specificity Survival Analysis Survival Rate Retrospective Studies Reproducibility of Results Prospective Studies Risk Factors Follow-Up Studies Questionnaires Risk Assessment Age Factors Risk Disease-Free Survival Predictive Value of Tests Registries Physician-Patient Relations Clinical Trials as Topic Palliative Care Odds Ratio Treatment Outcome Genetic Testing SEER Program Multivariate Analysis National Cancer Institute (U.S.)Incidence Oncology Service, Hospital Physician's Practice Patterns Attitude of Health Personnel Logistic Models Referral and Consultation Limit of Detection Kaplan-Meier Estimate ROC Curve Physicians Cohort Studies Case-Control Studies Confidence Intervals Cancer Care Facilities Pilot Projects American Cancer Society Health Care Surveys Practice Guidelines as Topic Terminal Care Prevalence Feasibility Studies Genetic Counseling

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Detection of Cancer Mammography Uterine Cervical Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Medical Oncology Vaginal Smears United States Neoplasms, Glandular and Epithelial Neoplasms Early Diagnosis Sensitivity and Specificity Radiation Oncology Tumor Markers, Biological CA-125 Antigen Prostatic Neoplasms Lung Neoplasms Antineoplastic Agents Cell Line, Tumor Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Prognosis Neoplasm Staging Genes, BRCA1 Carcinoma Neoplasm Invasiveness Mice, Nude Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Neoplasm Proteins Drug Resistance, Neoplasm Survival Analysis Antineoplastic Combined Chemotherapy Protocols Pancreatic Neoplasms Genetic Predisposition to Disease Survival Rate Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Reproducibility of Results Prospective Studies Risk Factors Neoplasm Recurrence, Local Disease Progression Cisplatin Gene Expression Profiling Follow-Up Studies Questionnaires Colorectal Neoplasms Genes, BRCA2 Paclitaxel Mutation Survivors Xenograft Model Antitumor Assays Risk Assessment Cancer Vaccines Age Factors RNA, Messenger Risk BRCA2 Protein Carcinoma, Squamous Cell Disease-Free Survival Chemotherapy, Adjuvant DNA, Neoplasm Predictive Value of Tests Combined Modality Therapy DNA Methylation Registries BRCA1 Protein Adenocarcinoma, Clear Cell Carcinoma, Non-Small-Cell Lung Time Factors Physician's Role Adenocarcinoma, Mucinous Tape Recording Blotting, Western Physician-Patient Relations Clinical Trials as Topic Endometrial Neoplasms Adenocarcinoma Palliative Care Peritoneal Neoplasms Carcinoma, Endometrioid Odds Ratio Treatment Outcome Genetic Testing Receptors, Estrogen Receptor, erbB-2 Neoplasm Transplantation SEER Program Tumor Cells, Cultured Oligonucleotide Array Sequence Analysis Urinary Bladder Neoplasms Germ-Line Mutation Antineoplastic Agents, Phytogenic Cell Proliferation Antigens, Neoplasm

No FAQ available that match "oncologists early ovarian cancer early detection of cancer"